Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJean-Louis Parmasad, Maxime W.C. Rousseaux|Cell Death and Disease|2024Cited by 6
Genetic and pharmacological reduction of CDK14 mitigates α-synuclein pathology in human neurons and in rodent models of Parkinson’s diseaseJean-Louis Parmasad, Maxime W.C. Rousseaux|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1